Alpha DNA Investment Management’s Cigna CI Stock Holding History

Alpha DNA Investment Management’s Portfolio CI Stock Details CI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-6,382	Closed	-$2.32M	–	210
2024 Q1	$2.32M	Buy	6,382 +3,654	+134%	+$1.2M	0.86%	13
2023 Q4	$817K	Sell	2,728 -3,345	-55%	-$978K	0.32%	61
2023 Q3	$1.74M	Buy	6,073 +1,943	+47%	+$554K	0.71%	28
2023 Q2	$1.16M	Sell	4,130 -2,945	-42%	-$767K	0.39%	43
2023 Q1	$1.81M	Buy	+7,075	New	+$2.06M	0.53%	23
2021 Q2	–	Sell	-16	Closed	-$3K	–	197
2021 Q1	$3K	Hold	16	–	–	﹤0.01%	460
2020 Q4	$3K	Buy	+16	New	+$3.14K	﹤0.01%	411

Other funds holding CI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alpha DNA Investment Management's CI Position: Q2 2024 in Review

Alpha DNA Investment Management sold out of Cigna (CI) in Q2 2024, closing a stake of 6,382 shares — an estimated $2.32M sold.

Alpha DNA Investment Management first reported a position in CI in Q4 2020 and held it in 7 quarters. The position peaked at $2.32M in Q1 2024. 1,663 funds tracked by Wall St. Rank hold CI as of Q2 2024.

Alpha DNA Investment Management reported no remaining Cigna position as of Q2 2024 after selling out during the quarter.
Alpha DNA Investment Management sold 6,382 Cigna shares in Q2 2024, an estimated $2.32M.
Alpha DNA Investment Management first reported a position in Cigna in Q4 2020 and held it in 7 quarters.
Alpha DNA Investment Management's Cigna position peaked at $2.32M in Q1 2024.
1,663 funds tracked by Wall St. Rank held Cigna as of Q2 2024.

Based on Alpha DNA Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.